89 cases of eosinophilic esophagitis identified from a systematic review of 3,655 patients undergoing oral immunotherapy. The dataset, published by figshare admin karger in May 2026, provides a descriptive synthesis of patient demographics, allergen types, and treatment outcomes. The overall pooled prevalence of EoE was 1.8%, with milk and egg OIT showing higher risks of 6.9% and 9.5% respectively.
Use Cases
- Analyze prevalence of eosinophilic esophagitis based on allergen type (peanut, milk, egg) mentioned in the description
- Study demographic risk factors based on the reported 74% male incidence
- Evaluate treatment outcomes based on reported proton pump inhibitor therapy and OIT discontinuation
Strengths
- Includes data from 13 studies comprising 3,655 patients
- Provides a pooled prevalence estimate of 1.8% with confidence intervals
- Compares risk across specific allergens (peanut, milk, egg)
Limitations
- Column-level documentation is absent; field semantics must be inferred after download
- Row count is unknown, which may limit suitability assessment
- Data is contained in a single DOCX file (314.9 KB), indicating a limited scope
Provenance
- Source
- figshare admin karger
- Collection Method
- Systematic review and meta-analysis of MEDLINE and Embase databases
- Time Range
- Studies from database inception to July 1, 2025
- Freshness
- Last updated 2026-05-08 07:55:12